NCT Number: NCT01711060
A Comparison of Balloon Catheter Versus Ocytocin for Cervical Ripening on Scarred Uterus With Unfavorable Cervix
Increasing cesarean rate in France is worrying. Different methods are described for ripening labor : the use of prostaglandins is described but maybe dangerous for patients with scarred uterus and is not recommended.
Intracervical balloon is an efficient alternative methods which as already been tested for unfavorable cervix ripening on nulliparous women.
But it was rarely tested on women with scared uterus and unfavorable cervix (bishop score <4).
The investigators propose a prospective randomised trial comparing cervix ripening with intracervical balloon inflated by 50 ml sterile water during 12 hours versus ocytocin (reference method).
The investigators expect to demonstrate what it's a safe method to increase vaginal delivery for women with previous cesarean section who need an induction of labour.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–45 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Service Gynécologie Obstétrique, Angoulême, France
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Pregnancy over 37 weeks
- Singleton pregnancy
- Vertex presentation
- Previous caesarean section with unique Transversal segmentary incision
- Medical indication of induction of labor
- Unfavorable cervix with Bishop score < 4
- No Premature Rupture Of Membranes
- Informed consent
Exclusion criteria
- Before 18 years old
- Placenta Praevia
- Premature Rupture Of Membranes
- Uterine scar other than transversal segmentary incision
- Cervical infection (except Streptoccoccus Agalactiae carrier) or choriamnionitis
- Multiple pregnancy
- Fetal malpresentation
- Cesarean indication
- Latex allergy
- No informed consent
Treatment and study plan
balloon catheter
ProcedurePrimary outcomes
-
Rate of childbirth by low way
The childbirth by low way being considered as a success of the treatment
Secondary outcomes
-
Rate of incidence of materno-fœtales morbidity
number
Sponsors and collaborators
Lead sponsor
Poitiers University Hospital
Other
Registry information
Important dates
- Study start
- 2010
- Primary completion
- 2014
- First posted
- Oct 22, 2012
- Registry last updated
- Oct 11, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Laminaria Japonicum Followed by Misoprostol Versus Misoprostol Alone for Mid-Trimester Abortion Induction in Scarred Uterus
NCT07465016
Induction of Abortion, Scarred Uterus
Cairo, Egypt
View Trial DetailsUterine Scar Resection During Repeat Cesarean Delivery to Prevent Uterine Niche Formation
NCT07228858
Cesarean Section Complications, Scar Niche
Banhā, Qalyubia Governorate, Egypt
View Trial DetailsBirth Cohort Study of China Medical University
NCT03561766
Advanced Maternal Age Pregnancy, Body Weight
Shenyang, Liaoning, China
View Trial Details